Project A.L.S.™ Funded Research
Current Grantees:
Robert H. Brown, Jr., M.D., D.Phil
Therapeutic strategies: RNAi
University of Massachusetts Medical School
Robert Brownstone, Ph.D.
Physiology & Function of ES Cell Derived Motor Neurons
Dalhousie University
Jeremy Dasen, D.Phil., Ph.D.
Linking Genetic Programs of Diversity to ES Cell Motor Neuron Connectivity
New York University
Elizabeth Gould, Ph.D.
The Spinal Nucleus of the Bulbocavernosus and Its Resistance to ALS
Princeton University
Harvard Neurodiscovery Center
Collaborative ALS Drug Discovery Initiative
Harvard Medical School
Christopher Henderson, Ph.D.
ES & iPS Cell Based Models of ALS and Drug Screening
Columbia University
Kevin Eggan, Ph.D.
Human ES and iPS Cell Based Models of ALS
Harvard University
Fred H. Gage
Motor Neurons from Neural Progenitors
The Salk Institute
Thomas M. Jessell, Ph.D.
Genetics & Physiological Analysis of Cholinergic Synapses on Motor Neurons
Howard Hughes Medical Institute,
Columbia University
Brian Kaspar, Ph.D
Motor Neurons from Neural Progenitors
Nationwide Children’s Hospital
Amy MacDermott, Ph.D.
Electrophysiology Measurements on Stem Cells
Columbia University
Tom Maniatis, Ph.D.
Biochemistry of ALS Pathogenesis
Columbia University
Richard Mann, Ph.D.
Role of Hox Genes in Motor Neuron Development and Function
Columbia University
Gareth Miles, Ph.D.
Genetics & Physiological Analysis of Cholinergic Synapses on Motor Neurons
University of St. Andrewsl
P2ALS
A Three-Year Mission Toward Understanding & Treating ALS
Project A.L.S.™ & Packard Center for ALS Research at Johns Hopkins University
Hynek Wichterle, Ph.D.
Linking Genetic Programs of Diversity to ES Cell Motor Neuron Connectivity
Columbia University
